Ixico Share Discussion Threads

[chrisdgb] 11/12/2024 08:22

Hoping this could be an interesting recovery play for 25'......

[40 fathoms] 20/11/2024 12:06

It is not always the case with Paul Hill— here he is so far off-piste I worry he might break something. Ixico is not a dominant player in AD; that's their view, not mine. They have potential but will need to run through early-stage trials first. The industry is moving towards AD diagnosis without imaging, as blood based biomarker technology starts to replace the need for PET, MRI or other imaging modalities. This technology is now validated and is now starting to be rolled out, though it will take time, as everything in this space does, but it is the direction of travel.

As for the AD post-market surveillance oportunity, Eisai's subcutaneous leqembi formulation, which will be on the market in the next 18 months, has much lower levels of ARIA than the infused version. Initial results from Roche's trontinemab phase 1b/2a clinical trial showed a significant reduction in ARIA occurrence compared to both leqembi and kinsula. This will need to be confirmed in a much larger trial, but again, the trend is towards much fewer ARIA-related events as DMT landscape develops.. If the trontinemab safety data is confirmed and it proves effective, there would be a strong case for discontinuing the FDA post-market surveillance requirements in place for all amyloid-clearing monoclonal antibodies.

[rolo7] 19/11/2024 12:50

Vox podcast video with Paul hill I could not buy any earlier

[chrisdgb] 19/11/2024 09:46

What has sparked the flurry recently here...?

[brummy_git] 02/11/2024 14:01

Thursday's article on IXICO published by Vox markets - "The brains behind brain scans."

[chrisdgb] 21/10/2024 10:26

Could recover very nicely here...

[40 fathoms] 06/8/2024 23:13

On paper at least a very strange choice for the new CEO, hard to see how he is going to change things meaningfully in the near/medium term. That said he should be given time to prove himself. Now they can focus on the a Capital Raise which they are going to need.

[40 fathoms] 19/6/2024 14:23

200k a year over 5 years is not going to fill the negative cash flow hole that they freely admit to. As you well know management will not let the cash balances go below a certain point. The old saying goes raise when you can, not when you have to. Any raise is going to hurt but they need to avoid a death rattle raise in which existing holders are completley crushed.

[citys2874] 19/6/2024 14:00

mms ready to let go

[citys2874] 19/6/2024 10:55

As of 29 February, Ixico said it maintained a robust balance sheet, with £2.8m in cash reserves with no outstanding debt. So plenty of cash. This is due a major bounce up

[citys2874] 19/6/2024 10:53

lovely £1million pound contract win today

[citys2874] 19/6/2024 10:53

(Sharecast News) - Precision analytics company Ixico announced a new contract valued at over £1m on Wednesday.
The AIM-traded firm said the contract, awarded by a top-five contract research organisation (CRO) on behalf of a new pharmaceutical client, would involve providing imaging biomarker services for a phase three clinical trial targeting a type of Parkinsonian disorder.

It said the trial was set to run for just under five years, further establishing Ixico's expertise and expanding its footprint in the neuroimaging and biomarker space.

"Following the new contract win announced on 23 May in Alzheimer's disease, we are delighted to be announcing the award of a contract from a new client to support the development of a promising treatment targeting a Parkinsonian disorder," said chief executive officer Giulio Cerroni.

"We are pleased that our expertise in providing imaging analysis and radiological reads across clinical trials for a broadening range of neurodegenerative disorders, is increasingly recognised across the drug development industry and continues to attract new sponsors seeking these expert services."

[citys2874] 19/6/2024 10:52

BUYING PRESSURE BUILDING UP SHOULD BREAKOUT THGIS AFTERNOON

[40 fathoms] 19/6/2024 10:04

It is going to need a lot more than GBP 1 million over 5 years to avoid a CR. According to their last IMC presentation they are @GBP 1.8 million per year of revenue short of cash flow breakeven.

[citys2874] 19/6/2024 08:32

7.50 paid and mms ready and primed to tick up

[citys2874] 19/6/2024 08:27

in the TOP 10 GAINER ON THE LEADERBOARD NOW ....MOVING UP SWIFTLY

[citys2874] 19/6/2024 08:22

market makers ticking up

[citys2874] 19/6/2024 08:21

up 12 percent

[chrisdgb] 19/6/2024 07:14

Great to see contract news like this, not only for the bottom line but also credibility.....

[citys2874] 19/6/2024 07:08

RNS OUT -£1M Contract win .....could see 10.00+ today

[citys2874] 19/6/2024 07:06

up 10 percent

[papillon] 10/6/2024 14:01

Have you finished pumping & dumping KPRZ, Cityspiv2874? 😂😂

[citys2874] 10/6/2024 13:27

reversal bounce breakout coming

[citys2874] 10/6/2024 13:27

up 3 percent moving up new contracts due